Belite Bio (BLTE) Cash from Operations (2020 - 2025)
Belite Bio (BLTE) posted quarterly Cash from Operations of 10385000.0 for Q4 2025, down 125.71% year-over-year from 40390012.68 in Q4 2024, and down 125.71% quarter-over-quarter from 4601000.0 in Q4 2024.
Powered by 
Analysis
Belite Bio (BLTE) Cash from Operations (2020 - 2025) Analysis & Trends
Belite Bio's Cash from Operations history runs 2 years deep, the most recent figure standing at 10385000.0 for Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -526.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -387.32 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 462.82 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 728.46 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Belite Bio | 6.44 Bn | 6.44 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -10.39 Mn |
| Dec 31, 2024 | -4.60 Mn |
| Dec 31, 2022 | -11.46 Mn |
| Dec 31, 2021 | -7.47 Mn |
| Dec 31, 2020 | -4.44 Mn |